Get started
Author

Roland Rapold

Observed names: R. Rapold, Rapold, R., Rapold, Roland, Rapold, Ronald
ORCID: 0000-0001-8287-290X
Observed ORCID: 0000-0001-8287-290X
OpenAlex ID: A5046192721
Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications
2013 · Carola A Huber, Thomas D Szucs, et al. · BMC Public Health · 217
PDF
Potentially Inappropriate Medication Use in Older Patients in Swiss Managed Care Plans: Prevalence, Determinants and Association with Hospitalization
2014 · Oliver Reich, Thomas Rosemann, et al. · PLoS ONE · 150
PDF
Polypharmacy and Potentially Inappropriate Medication in the Adult, Community-Dwelling Population in Switzerland
2013 · Eva Blozik, Roland Rapold, et al. · Drugs & Aging · 92
Epidemiology and costs of diabetes mellitus in Switzerland: an analysis of health care claims data, 2006 and 2011
2014 · Carola A Huber, Matthias Schwenkglenks, et al. · BMC Endocrine Disorders · 68
PDF
An empirical investigation of the efficiency effects of integrated care models in Switzerland
2012 · Oliver Reich, Roland Rapold, et al. · International Journal of Integrated Care · 65
The relationship between functional health literacy and the use of the health system by diabetics in Switzerland
2013 · J. Franzen, S. Mantwill, et al. · European Journal of Public Health · 49
PDF
One-year adherence to oral antihyperglycemic medication and risk prediction of patient outcomes for adults with diabetes mellitus
2016 · Carola A. Huber, Roland Rapold, et al. · Medicine · 44
Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland
2014 · Carola Huber, Peter Diem, et al. · Diabetes Metabolic Syndrome and Obesity · 32
PDF
Epidemiology and costs of multiple sclerosis in Switzerland: an analysis of health-care claims data, 2011–2015
2017 · Eva Blozik, Roland Rapold, et al. · Neuropsychiatric Disease and Treatment · 24
PDF
A set of four simple performance measures reflecting adherence to guidelines predicts hospitalization: a claims-based cohort study of patients with diabetes
2016 · Carola A Huber, Michael Brändle, et al. · Patient Preference and Adherence · 21
PDF
Evidence-based quality indicators for primary healthcare in association with the risk of hospitalisation: a population-based cohort study in Switzerland
2020 · Carola A Huber, Martin Scherer, et al. · BMJ Open · 19
PDF
Evidence-based indicators for the measurement of quality of primary care using health insurance claims data in Switzerland: results of a pragmatic consensus process
2018 · Swiss Quality Indicator for Primary Care (SQIPRICA) Working Group, Eva Blozik, et al. · BMC Health Services Research · 17
PDF
Prescription of potentially inappropriate medication in older persons in Switzerland: does the dispensing channel make a difference?
2015 · Eva Blozik, Roland Rapold, et al. · Risk Management and Healthcare Policy · 17
PDF
Anti-VEGF treatment patterns and associated health care costs in Switzerland: findings using real-world claims data
2015 · Oliver Reich, Lucas Bachmann, et al. · Risk Management and Healthcare Policy · 16
PDF
Cancer-Related Therapies at the End of Life in Hospitalized Cancer Patients from Four Swiss Cantons: SAKK 89/09
2014 · Klazien W. Matter-Walstra, Rita Achermann, et al. · Oncology · 16
PDF
Delivery of health care at the end of life in cancer patients of four swiss cantons: a retrospective database study (SAKK 89/09)
2014 · Klazien W Matter-Walstra, Rita Achermann, et al. · BMC Cancer · 16
PDF
Injections frequency and health care costs in patients treated with aflibercept compared to ranibizumab: new real-life evidence from Switzerland
2017 · Oliver Reich, Martin K. Schmid, et al. · BMC Ophthalmology · 13
PDF
Regional differences in healthcare costs at the end of life: an observational study using Swiss insurance claims data
2020 · Caroline Bähler, Roland Rapold, et al. · International Journal of Public Health · 9
Days spent in acute care hospitals at the end of life of cancer patients in four Swiss cantons: a retrospective database study (SAKK 89/09)
2016 · K.W. Matter-Walstra, R. Achermann, et al. · European Journal of Cancer Care · 9
PDF
Outcomes and costs of Ranibizumab and Aflibercept treatment in a health-service research context
2018 · Martin K. Schmid, Oliver Reich, et al. · BMC Ophthalmology · 5
PDF
Late Breaking Abstract - Assessing epidemiology and costs of asthma and COPD in Switzerland with health insurance data
2018 · Marion Schmidt, Beatrice Brunner, et al. · European Respiratory Journal · 1
Asthma and COPD in Switzerland : prevalence and direct medical costs according to health insurance claims data and a large population survey
2018 · Marion Schmidt, Roland Rapold, et al. · Zürcher Hochschule für Angewandte Wissenschaften digital collection (Zurich University of Applied Sciences) · 1
Der Patient im Managed-Care-Modell oder der Arzt als Teil eines Ärztenetzes: Was führt zum Effizienzgewinn?
2017 · Oliver Reich, Roland Rapold, et al. · Praxis · 1
Pcn312 Multiple Myeloma in a Swiss Population: Real-world Drug Regimens and Costs of Treatment (2012 to 2017)
2019 · K. Eichler, R. Rapold, et al. · Value in Health
PDF
Real-world Drug Regimens for Multiple Myeloma in a Swiss Population (2012 to 2017): cost-outcome description
2019 · Klaus Eichler, Roland Rapold, et al. · medRxiv
PDF
Works count: 33
Citation count: 902
H-index: 16
I10-index: 17
Year
Topic
Type